News

The American Journal of Managed Care21h
Linvoseltamab Added as Preferred Agent in Newest MM Practice Guidelines
On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...
FoodNavigator-USA8d
FDA’s 2025 Food Agenda: What industry must know
Explore the FDA’s 2025 Human Foods Program Guidance Agenda and what it means for US food and beverage businesses. Key ...
MedPage Today1d
Want to Judge Data on FDA-Cleared AI Systems for Alzheimer's? Good Luck With That
Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...
If you bought deodorant at Walmart or Dollar Tree, the FDA has an urgent warning
Three specific Power Stick antiperspirant varieties are being recalled nationwide after failing to meet safety manufacturing ...
Medscape1y
FDA's New Guidance for Early Alzheimer's Drug Development
The FDA noted that a key principle in developing guidance for early AD therapies is that treatment "must begin before there are overt clinical symptoms." "We enthusiastically support this idea ...
STAT6mon
FDA's draft guidance on use of AI in drug development centers risk - STAT
The FDA’s new draft guidance comes on the heels of a reflection paper from the European Medicines Agency on the use of AI in the drug product lifecycle, finalized in September 2024.